CSRXP STATEMENT ON CONFIRMATION OF DR. ROBERT CALIFF AS COMMISSIONER OF U.S. FOOD AND DRUG ADMINISTRATION
Feb 15, 2022
FDA Can Play a Critical Role in Holding Big Pharma Accountable and Promoting… Read More
© 2024 CSRXP- All Rights Reserved
Press & Statements
CSRXP POLL: VOTERS SEE THROUGH BIG PHARMA’S BLAME GAME, WANT WASHINGTON TO LOWER DRUG PRICES & HOLD DRUG COMPANIES ACCOUNTABLE
Feb 7, 2022
Broad Majorities of Americans Blame Pharmaceutical Industry for Out-of-Control… Read More
CSRXP: BIG PHARMA’S BUSINESS-AS-USUAL APPROACH TO JANUARY PRICE HIKES UNDERSCORES URGENCY FOR RX SOLUTIONS
Feb 2, 2022
Drug Companies Increased Prices on 785 Brand Name Products in First Month of… Read More
CSRXP STATEMENT ON PROPOSED CMS COVERAGE DECISION FOR ADUHELM
Jan 12, 2022
DECISION WILL HELP PROTECT SENIORS, TAXPAYERS AND THE U.S. HEALTH SYSTEM FROM… Read More
CSRXP STATEMENT AHEAD OF COMMITTEE VOTE FOR DR. ROBERT CALIFF TO LEAD U.S. FOOD AND DRUG ADMINISTRATION
Jan 12, 2022
Next FDA Commissioner Must Promote Competition, Transparency And Value In The… Read More
HAPPY NEW YEAR: BIG PHARMA HIKES PRICES ON MORE THAN 400 BRAND NAME DRUGS TO RING IN 2022
Jan 3, 2022
Fourth Major Round Of Pandemic Price Hikes Highlight Urgency for Policymakers… Read More
CSRXP: LANDMARK OVERSIGHT REPORT DEBUNKS BIG PHARMA’S FALSE RHETORIC, ADDS TO MOMENTUM TO LOWER RX PRICES
Dec 10, 2021
U.S. House Oversight & Reform Committee Report Finds Big Pharma’s… Read More
CSRxP: U.S. House Adds to Unprecedented Momentum to Hold Big Pharma Accountable with Passage of Rx Solutions in Build Back Better
Nov 19, 2021
Congress Must Capitalize on Historic Opportunity to Lower Drug Prices… Read More
CSRXP: BIG PHARMA’S EGREGIOUS PRICING OF UNPROVEN ALZHEIMER’S TREATMENT DRIVES HIGHER PREMIUMS FOR SENIORS
Nov 12, 2021
Biogen’s Staggering $56,000 Price Tag for Treatment With No Proven Clinical… Read More
CSRXP APPLAUDS INCLUSION OF PRESCRIPTION DRUG PRICING SOLUTIONS IN LATEST FRAMEWORK
Nov 2, 2021
Congress Should Reject Pharma-backed Proposals That Would Hike Health Care… Read More
CSRXP: WHITE HOUSE FRAMEWORK FAILS ON PROMISE TO LOWER DRUG PRICES
Oct 28, 2021
Framework Fails to Hold Big Pharma Accountable and Lower Drug Prices for the… Read More
CSRXP WELCOMES FDA APPROVAL OF FIRST INTERCHANGEABLE BIOSIMILAR FOR HUMIRA AS POSITIVE FIRST STEP
Oct 20, 2021
U.S. Food & Drug Administration Approval of Cyltezo Marks Second… Read More